CCND2 and chronic myelogenous leukemia, BCR-ABL1 positive: Similar results were obtained using human BM-MSCs in coculture with chronic myeloid leukemia (CML), acute myeloid leukemia (AML) and T-ALL cell lines, showing significantly reduced cyclin D2 activity and subsequent G1 phase blockade [116].